The invention is directed to novel sEH inhibitors and their use in the treatment of diseases mediated by the sEH enzyme.
本发明涉及新型sEH抑制剂及其在治疗由sEH酶介导的疾病中的应用。
NOVEL SEH INHIBITORS AND THEIR USE
申请人:Smithkline Beecham Corporation
公开号:EP2097378A1
公开(公告)日:2009-09-09
US7994317B2
申请人:——
公开号:US7994317B2
公开(公告)日:2011-08-09
[EN] NOVEL SEH INHIBITORS AND THEIR USE<br/>[FR] NOUVEAUX INHIBITEURS DE SEH ET UTILISATION DE CES DERNIERS
申请人:SMITHKLINE BEECHAM CORP
公开号:WO2008105968A1
公开(公告)日:2008-09-04
[EN] The invention is directed to novel sEH inhibitors and their use in the treatment of diseases mediated by the sEH enzyme. [FR] La présente invention concerne de nouveaux inhibiteurs de sEH et l'utilisation de ces derniers dans le traitement de maladies médiées par l'enzyme sEH.